• Zions Bancorporation, National Association recently completed a US$500,000,000 fixed-to-floating rate senior note offering due October 1, 2029, while also reporting second-quarter 2026 results that showed higher net interest income and net income versus the prior year.
• Alongside this earnings strength, Zions finished a US$75,000,000 share repurchase program in the quarter, signaling active balance sheet and capital management.
• With these stronger quarterly earnings and completed buybacks, we’ll now examine how this momentum may influence Zions Bancorporation’s investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Zions Bancorporation National Association Investment Narrative Recap

To own Zions Bancorporation, National Association, you need to be comfortable with a regional U.S. bank that leans heavily on Western markets and disciplined credit risk, while working to grow fee income and digital capabilities. The recent US$500,000,000 fixed to floating senior notes and stronger Q2 2026 earnings support near term capital flexibility, but do not materially change the key risk around credit quality in commercial real estate and regionally concentrated loan books.

The completion of the US$75,000,000 share repurchase program in Q2 2026 sits squarely in this context, as it directly interacts with Zions' capital position at a time when earnings are higher and regulators remain focused on regional bank resilience. How comfortably Zions can keep returning capital while managing potential pressures on deposit costs and credit losses will be central to how this story plays out over time.

Yet behind the stronger quarter, investors should still be aware of how exposed Zions remains to concentrated Western markets and...

Zions Bancorporation National Association's narrative projects $3.8 billion revenue and $913.1 million earnings by 2029. This assumes fairly flat yearly revenue and an earnings decrease of about $300 million from around $1.2 billion today.

Uncover how Zions Bancorporation National Association's forecasts yield a $74.71 fair value, a 7% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community now value Zions anywhere between about US$74 and over US$44,000 per share, showing just how far apart individual expectations can be. Against that wide spread, the core risk around regional credit concentration and commercial real estate exposure is a reminder to weigh multiple viewpoints before deciding what the recent funding and buyback activity might really mean for future performance.

Explore 3 other fair value estimates on Zions Bancorporation National Association - why the stock might be worth just $74.71!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Zions Bancorporation National Association research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Zions Bancorporation National Association research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Zions Bancorporation National Association's overall financial health at a glance.

No Opportunity In Zions Bancorporation National Association?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.